It primarily stems from a lack of balance between calorie intake and usage
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently unapproved by the MHRA, EMA, or FDA for routine clinical use
Chicken breast, turkey, tuna, cod, eggs, Greek yogurt, cottage cheese, tofu, or edamame can fit into a meal without creating the heavy, overly full feeling that larger mixed dishes sometimes cause
Examples of other GLP-1 agonists are: Tirzepatide ( Zepbound , Mounjaro ), which is a dual GLP-1 GIP agonist Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) Exenatide (Byetta) Lixisenatide (Adlyxin) Exendin-4 There are many other non-GLP-1 agonists used to treat diabetes as well